You are here

Merck Commits an Additional $10 Million to COVID-19 Relief

Merck Commits an Additional $10 Million to COVID-19 Relief

Tuesday, May 5, 2020

On Giving Tuesday, Merck and the Merck Foundation announced the company will make an additional commitment of $10 million in support of COVID-19 relief efforts to help address health disparities and inequality among patients and communities.

With this commitment, Merck has contributed or committed more than $30 million in support of global, national and local COVID-19 relief efforts.

Merck says that in the United States, statistics show that COVID-19 is disproportionately impacting communities and under-represented groups across the nation. Globally, pre-existing inequalities within society are also differentiating the impact of the disease. Approximately 90 percent of hospitalized patients have one or more underlying health conditions according to data from the Centers for Disease Control and Prevention (CDC).

“COVID-19 is an unprecedented challenge for the global community. At Merck, we are working to support patients, health care professionals and communities across the world in the fight against this disease,” said Merck Chief Patient Officer Dr. Julie Gerberding in a prepared statement. “This new commitment will help advance health equity and address social determinants of health in our most vulnerable communities and patient populations.”